GENETIC MARKERS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

摘要

The present invention regards expression profiles of one or more nucleic acids indicative of the presence of, susceptibility to, and/or predicting response to therapy of benign prostatic hyperplasia (BPH) in an individual. The present invention identifies pathways not previously associated with BPH, therefore presenting novel diagnostic and therapeutic targets for the condition.